Selection from HEOR Bibliography
| Search criteria | ||||
| Portugal |
||||
| Uncovering the burden of influenza in children in Portugal, 2008–2018 | ||||
| Alberto Caldas Afonso 1 2 3 4, Catarina Gouveia 5 6, Gustavo Januário 7 8, Mafalda Carmo 9, Hugo Lopes 10 11 12, Hélène Bricout 13, Catarina Gomes 14, Filipe Froes 15 | ||||
| 1Unidade de Nefrologia Pediátrica, Centro Materno-Infantil do Norte, Centro Hospitalar Universitário do Porto, Porto, Portugal. caldasafonso.cmin@chporto.min-saude.pt. 2Centro Hospitalar Universitário Santo António, Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal. caldasafonso.cmin@chporto.min-saude.pt. 3EPIUnit - Instituto de Saúde Pública, Porto, Portugal. caldasafonso.cmin@chporto.min-saude.pt. 4Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional, Porto, Portugal. caldasafonso.cmin@chporto.min-saude.pt. 5Hospital D. Estefânia, Centro Hospitalar Lisboa Central, Lisboa, Portugal. 6Faculdade de Ciências Médicas, Nova Medical School, Lisbon, Portugal. 7Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. 8Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal. 9IQVIA, Barcelona, Spain. 10IQVIA, Lisbon, Portugal. 11NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisbon, Portugal. 12Comprehensive Health Research Center - Universidade NOVA de Lisboa, Lisbon, Portugal. 13Sanofi, Lyon, France. 14Sanofi, Lisbon, Portugal. 15Hospital Pulido Valente, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal. | ||||
| Caldas Afonso A, Gouveia C, Januário G, Carmo M, Lopes H, Bricout H, Gomes C, Froes F. Uncovering the burden of Influenza in children in Portugal, 2008-2018. BMC Infect Dis. 2024 Jan 18;24(1):100. doi: 10.1186/s12879-023-08685-z. PMID: 38238649; PMCID: PMC10797867. |
||||
| , Article | ||||
| , Portugal | ||||
| Abstract: https://pubmed.ncbi.nlm.nih.gov/38238649/#:~:text=Influenza%2Dassociated%20excess%20hospitalizations%20between,1%2C879%20in%20all%2Dcause%20models | ||||
| Condition | Year | Language | Analysis type | |
| , Infectious disease, Respiratory disease | 2024 | English | , Burden of illness | |
| Addressing influenza's underestimated burden - Iberian experts call to action | ||||
| Ángel Gil-de-Miguel 1 2, Javier Díez-Domingo 3, Federico Martinón-Torres 4 5 6, Esther Redondo Margüello 7, Raúl Ortiz de Lejarazu Leonardo 8, Tomàs Pumarola 9, Jaime Correia de Sousa 10, Carlos Rabaçal 11, João Raposo 12, Carlos Robalo Cordeiro 13, Filipe Froes 14 | ||||
| 1Public Health and Medical Specialties Department, Health Sciences Faculty, Rey Juan Carlos University, Madrid, Spain. angel.gil@urjc.es. 2Universidad Rey Juan Carlos, Avda. de Atenas, s/n, 28922, Alcorcón, Madrid, Spain. angel.gil@urjc.es. 3Vaccine Research Department, University of Valencia, Valencia, Spain. 4Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario and Universidad de Santiago de Compostela, Galicia, Spain. 5Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago and Universidad de Santiago de Compostela (USC), Galicia, Spain. 6CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain. 7International Health Center Madrid Health, City Council of Madrid, Madrid, Spain. 8National Influenza Centre, Hospital Clínico Universitario, Universidad de Valladolid, Valladolid, Spain. 9Department of Microbiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain. 10Life and Health Sciences Research Institute (ICVS), School of Medicine, PT Government Associate Laboratory, University of Minho, Braga Portugal. ICVS/3B's, Braga/Guimarães, Portugal. 11Vila Franca de Xira Hospital, Lisbon, Portugal. 12APDP and Nova Medical School, Lisbon, Portugal. 13Pulmonology Department, Coimbra University Hospital, University of Coimbra, Coimbra, Portugal. 14Thorax Department, ICU, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal. | ||||
| , Article | ||||
| , Portugal, Spain | ||||
| Abstract: https://pubmed.ncbi.nlm.nih.gov/37158822/ | ||||
| Condition | Year | Language | Analysis type | |
| , Infectious disease, Respiratory disease | 2023 | English | , Burden of illness | |
| Burden and severity of children's hospitalizations by respiratory syncytial virus in Portugal, 2015-2018 | ||||
| Teresa Bandeira 1, Mafalda Carmo 2, Hugo Lopes 3, Catarina Gomes 4, Margarida Martins 4, Carlos Guzman 5, Mathieu Bangert 6, Fernanda Rodrigues 7 8, Gustavo Januário 7 8, Teresa Tomé 9, Inês Azevedo 10 | ||||
| 1Centro Hospitalar Universitário Lisboa Norte, Faculdade de Medicina, Universidade de Lisboa, CAML, Lisbon, Portugal. 2IQVIA, Barcelona, Spain. 3IQVIA, Lisbon, Portugal. 4Sanofi, Lisbon, Portugal. 5Sanofi, Madrid, Spain. 6Sanofi, Lyon, France. 7Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal. 8Faculdade de Medicina, Universidade de Coimbra, Coimbra, Portugal. 9Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal. 10Faculdade de Medicina, Universidade do Porto, Centro Hospitalar Universitário S. João; EPIUnit, Instituto de Saúde Pública, Porto, Portugal. | ||||
| , Article | ||||
| , Portugal | ||||
| Abstract: https://pubmed.ncbi.nlm.nih.gov/36377322/ | ||||
| Condition | Year | Language | Analysis type | |
| , Infectious disease, Respiratory disease | 2023 | English | , Burden of illness | |
| Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 | ||||
| Janet Sultana 1 2, Salvatore Crisafulli 3, Mariana Almas 4, Ippazio Cosimo Antonazzo 5 6, Esme Baan 7, Claudia Bartolini 6, Maria Paola Bertuccio 3, Fedele Bonifazi 8 9, Annalisa Capuano 10 11, Antonella Didio 8 9, Vera Ehrenstein 12, Mariagrazia Felisi 8 13, Carmen Ferrajolo 10 11, Andrea Fontana 14, Remy Francisca 7, Annie Fourrier-Reglat 15, Joan Fortuny 16, Rosa Gini 6, Giulia Hyeraci 6, Christel Hoeve 7, Christos Kontogiorgis 17, Valentina Isgrò 18, Panagiotis-Nikolaos Lalagkas 17, Luca L'Abbate 18, Deborah Layton 19, Annalisa Landi 8 9, Silvia Narduzzi 19, Leonardo Roque Pereira 20, Georgios Poulentzas 17, Concetta Rafaniello 10 11, Giuseppe Roberto 6, Giulia Scondotto 3, Liberata Sportiello 10 11, Maddalena Toma 8 9, Massoud Toussi 19, Katia Verhamme 7, Elisabetta Volpe 8 9, Gianluca Trifirò 18, | ||||
| Pharmacy Department, Mater Dei Hospital, Msida, Malta. 2Exeter College of Medicine and Health, Exeter, UK. 3Department of Medicine, University of Verona, Verona, Italy. 4Real World Solutions Department, IQVIA, Lisbon, Portugal. 5Research Centre on Public Health (CESP), University of Milan-Bicocca, Milan, Italy. 6Agenzia Regionale di Sanità della Toscana, Florence, Italy. 7Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, The Netherlands. 8TEDDY European Network of Excellence for Paediatric Clinical Research, Pavia, Italy. 9Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, Bari, Italy. 10Department of Experimental Medicine, University of Campania "Vanvitelli", Naples, Italy. 11Campania Regional Center of Pharmacovigilance and Pharmacoepidemiology, Naples, Italy. 12Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark. 13CVBF Consorzio per Valutazioni Biologiche e Farmacologiche, Pavia, Italy. 14Unit of Biostatistics, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. 15Univ. Bordeaux, INSERM, Bordeaux Population Health Research Center, Team of Pharmacoepidemiology, UMR 1219, Bordeaux, France. 16RTI Health Solutions, Barcelona, Spain. 17Democritus University of Thrace, Alexandroupolis, Greece. 18Department of Diagnostics and Public Health, University of Verona, Verona, Italy. 19Data Science Hub, Real World Solutions, IQVIA, London, UK. 20Department of Datascience & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands. | ||||
| Pharmacoepidemiol Drug Saf . 2022 Jun;31(6):689-705. doi: 10.1002/pds.5413. Epub 2022 Feb 11. |
||||
| , Article | ||||
| , Denmark, France, Italy, Netherlands, Portugal, Spain, UK | ||||
| Abstract: https://pubmed.ncbi.nlm.nih.gov/35092329/ | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Drug Utlization Study | 2022 | English | , Database Study, Review | |
| Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal | ||||
| Nuno Marques 1, Laetitia Gerlier 2, Mafalda Ramos 3, Helder Pereira 4, Sérgia Rocha 5, Ana Catarina Fonseca 6, Ana André 7, Ricardo Melo 8, Eduard Sidelnikov 9 | ||||
| 1Department of Cardiology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal. 2IQVIA, Zaventem, Belgium. 3IQVIA, Zaventem, Belgium. Electronic address: mafalda.ramos@iqvia.com. 4Department of Cardiology, Hospital Garcia de Orta, Almada, Portugal. 5Department of Cardiology, Hospital de Braga, Braga, Portugal. 6Department of Neurology, Hospital de Santa Maria, Universidade de Lisboa, Lisboa, Portugal. 7Department of Neurology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal. 8Amgen SA, Portugal. 9Amgen (Europe) GmbH, Rotkreuz, Switzerland. | ||||
| PMID: 33581948 DOI: 10.1016/j.repc.2020.05.019 IQVIA HEOR Zaventem Brussels Revista Portuguesa de Cardiologia Volume 40, Issue 2, February 2021, Pages 109-115. |
||||
| , Article | ||||
| , Portugal | ||||
| Abstract: https://pubmed.ncbi.nlm.nih.gov/33581948/ | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Health economics | 2021 | English | , Burden of illness, Clinical setting: Primary care, Prospective study | |
| The Burden Of Hpv In Head And Neck Cancers - Design Of The Broaden Study | ||||
| Gómez Ulloa D1, Morais E2, Fenoll R1, Kothari S3, Giuliano A4, Mirghani H5, Mehanna H6, Waterboer T7, Roberts C3, Varga S3, Tu Y3, Pérez G3, Saah A3, Alemany L8 | ||||
| 1 IQVIA, Barcelona, Spain 2 MSD, CORE, Lyon, France 3 Merck & Co. Inc., Center for Observational and Real-world Evidence, Kenilworth, NJ, US 4 Moffitt Cancer Center and Research Institute, Center for Immunization and Infection Research in Cancer, Tampa, FL, US 5 HEGP, ORL, Paris, France 6 InHANSE, Head and Neck Surgery, Birmingham, UK 7 German Cancer Research Center (DKFZ), Infections and Cancer Epidemiology, Heidelberg, Germany 8 Catalan Institute of Oncology - IDIBELL, On behalf of Unit of Cancer and Infection in the Cancer Epidemiology Research Programme, Hospitalet Del Llobregat, Spain | ||||
| IPVC, Barcelona, Spain, 23-27 March 2020 |
||||
| , Oral presentation | ||||
| , China, France, Germany, Italy, Japan, Portugal, Spain | ||||
| Condition | Year | Language | Analysis type | |
| , Infectious disease, Oncology | 2020 | English | , Burden of illness, Observational study, Retrospective Field Study | |
| EVALUATION OF THE EFFECTIVENESS OF RISK MINIMISATION MEASURES TARGETING PHYSICIANS ON PRESCRIBING PRACTICES OF THIOCOLCHICOSIDE (TCC) CONTAINING MEDICINAL PRODUCTS FOR SYSTEMIC USE | ||||
| Laurence Sophie Jouaville, Carole Ehrhardt, Marie-Laure Kürzinger, Hanka de Voogd, Massoud Toussi | ||||
| Real World Evidence Solutions, IQVIA, France; Global Pharmacovigilance – Global Safety Sciences - Risk Management, Sanofi; Epidemiology and Benefit Risk Evaluation, Sanofi; Global Clinical Sciences; Vaccines & Anti-Infectives, Mylan, The Netherlands | ||||
| Poster presented at: 35th International Conference an Pharmacoepidemiology and Therapeutic Risk Management (ICPE) Pennsylvania Convention Center Philadelphia, Pennsylvania August 24-28, 2019 |
||||
| , Poster | ||||
| , France, Greece, Italy, Portugal | ||||
| Abstract: https://www.coodoc.com/pages/p1819-Thiocholchicoside-ICPE-2019 | ||||
| Condition | Year | Language | Analysis type | |
| , Health policy, Musculoskeletal disease | 2019 | English | , Survey research | |
| Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe | ||||
| Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Amarenco P4, Annemans L5 | ||||
| 1 Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK 2 IQVIA, Zaventem, Belgium 3 Amgen (Europe) GmbH, Rotkreuz, Switzerland 4 Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France 5 University of Ghent, Belgium | ||||
| Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157. |
||||
| , Article | ||||
| , Belgium, France, Poland, Portugal, Spain, Switzerland, UK | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30955367 | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Health economics | 2019 | English | , Burden of illness, Clinical setting: Primary care, direct to patient research, Observational study | |
| Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use | ||||
| Jouaville LS, Ehrhardt C, Kürzinger ML, de Voogd H, Toussi M | ||||
| IQVIA | ||||
| Epidemiology (Sunnyvale) 9: 372. DOI: 10.4172/2161-1165.1000372 |
||||
| , Article | ||||
| , France, Greece, Italy, Portugal | ||||
| Abstract: https://www.omicsonline.org/open-access/evaluation-of-the-effectiveness-of-risk-minimisation-measures-targeting-physicians-on-prescribing-practices-of-thiocolchicoside-co-2161-1165-1000372-108159.html | ||||
| Condition | Year | Language | Analysis type | |
| , Musculoskeletal disease, Rheumatology, Risk Management & REMS | 2019 | English | , Survey research | |
| Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe. | ||||
| Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Annemans L4, Amarenco P5 | ||||
| 1 Imperial College London, London, United Kingdom 2 IQVIA, Zaventem, Belgium 3 Amgen Europe GmbH, Zug, Switzerland 4 Ghent University, Ghent, Belgium 5 Hospital Bichat-Claude Bernard, Paris, France | ||||
| European Society of Cardiology (ESC) Congress, 2018, Munich, Germany |
||||
| , Poster | ||||
| , Belgium, France, Poland, Portugal, Spain, Switzerland, UK | ||||
| Abstract: https://esc365.escardio.org/Congress/ESC-Congress-2018/Poster-Session-3-Health-economics/176943-patient-and-caregiver-productivity-loss-and-indirect-costs-associated-with-cardiovascular-events-in-europe | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease, Health economics | 2018 | English | , Burden of illness, Cost of illness | |
| Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model | ||||
| Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7 | ||||
| 1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany | ||||
| JHEOR 2017;5(1):89-108 |
||||
| , Article | ||||
| , Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Immunology and Vaccination, Infectious disease, Respiratory disease | 2017 | English | , Epidemiological study, Public Health | |
| Stage-specific survival and recurrence in patients with cutaneous malignant melanoma in Europe - a systematic review of the literature. | ||||
| Svedman FC1, Pillas D2, Taylor A2, Kaur M2, Linder R3, Hansson J1. | ||||
| 1Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden. 2Centre for Observational Research, Amgen Ltd, Uxbridge, UK. 3IMS Health Sweden, Stockholm, Sweden. | ||||
| Clinical Epidemiology |
||||
| , Article | ||||
| , Australia, Austria, Belgium, Bulgaria, Croatia, Czech, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, Norway, Poland, Portugal, Russian Federation, Serbia and Montenegro, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK | ||||
| Abstract: http://www-ncbi-nlm-nih-gov.proxy.kib.ki.se/pmc/articles/PMC4887072/ | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2016 | English | , Literature Review | |
| Rationale and design of a multi-center survey to evaluate productivity losses and indirect costs after cardiovascular events in Europe. | ||||
| Gerlier L1, Sidelnikov E2, Kutikova L2, Lamotte M1, Annemans L3 | ||||
| 1 QuintilesIMS, Zaventem, Belgium 2 Amgen (Europe) GmbH, Zug, Switzerland 3 University of Ghent, Ghent, Belgium | ||||
| 19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
| , Abstract | ||||
| , Belgium, Czech, France, Germany, Hungary, Italy, Poland, Portugal, Romania, Spain, Switzerland, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease | 2016 | English | ||
| Liver transplant associated with paracetamol overdose: results from the seven-country SALT study | ||||
| Sinem Ezgi Gulmez,1 Dominique Larrey,2 Georges- Philippe Pageaux,2 Jacques Bernuau,3 Franco Bissoli,4 Yves Horsmans,5 Douglas Thorburn,6 P. Aiden McCormick,7 Bruno Stricker,8 Massoud Toussi,9 Séverine Lignot-Maleyran,1 Sophie Micon,1 Fatima Hamoud,1 Régis Lassalle,1 Jérémy Jové,1 Patrick Blin1 & Nicholas Moore1 | ||||
| 1CIC Bordeaux CIC1401 Pharmaco-épidémiologie, Université de Bordeaux, F-33076 Bordeaux, France, 2CHU St Eloi Hospital, Liver Unit, Montpellier, France, 3Beaujon Hospital, Liver Unit, Clichy, France, 4Department of Internal Medicine, Clinica San Gaudenzio, Novara, Italy, 5Department of Gastroenterology, Louvain Catholic University, Louvain, Belgium, 6Liver Unit, Royal Free NHS Trust, London, UK, 7Liver Unit, St Vincent’s University Hospital and University College Dublin, Dublin, Ireland, 8Department of Epidemiology, Erasmus University, Rotterdam, Netherlands and 9IMSHealth, Real World Evidence Solutions, France | ||||
| British Journal of Clinical Pharmacology 2015 |
||||
| , Article | ||||
| , France, Greece, Ireland, Italy, Netherlands, Portugal, UK | ||||
| Condition | Year | Language | Analysis type | |
| , Drug safety, Public Health | 2015 | English | , Epidemiological study | |
| Survey on appropriateness of use of nimesulide in nine European countries | ||||
| Franchi S1, Heiman F2, Visentin E2, Sacerdote P1. | ||||
| 1Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy. 2Cegedim Strategic Data Medical Research Srl, Milan, Italy. | ||||
| Drug, Healthcare and Patient Safety 2015:7 51-55 |
||||
| , Article | ||||
| , Bulgaria, Czech, Greece, Hungary, Italy, Poland, Portugal, Romania, Slovakia | ||||
| Condition | Year | Language | Analysis type | |
| , Pain | 2015 | English | , Survey research | |
| Rituximab versus an alternative TNF inhibitor in patients with rheumatoid arthritis who failed to respond to a single previous TNF inhibitor: SWITCH-RA, a global, observational, comparative effectiveness study. | ||||
| Emery P1, Gottenberg JE2, Rubbert-Roth A3, Sarzi-Puttini P4, Choquette D5, Taboada VM6, Barile-Fabris L7, Moots RJ8, Ostor A9, Andrianakos A10, Gemmen E11, Mpofu C12, Chung C13, Gylvin LH12, Finckh A14. | ||||
| 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK. 2Department of Rheumatology, CHU Strasbourg, Strasbourg, France. 3University of Cologne, Cologne, Germany. 4L Sacco University Hospital, Milan, Italy. 5University of Montreal, Montreal, Canada. 6Facultad de Medicina, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain. 7Hospital de Especialidades Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México City, Mexico. 8Department of Rheumatology, University of Liverpool, Liverpool, UK. 9Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. 10Hellenic Foundation for Rheumatological Research, Athens, Greece. 11Quintiles, Rockville, Maryland, USA. 12F Hoffmann-La Roche Ltd, Basel, Switzerland. 13Genentech Inc, San Francisco, California, USA. 14University Hospital of Geneva, Geneva, Switzerland. | ||||
| Ann Rheum Dis. 2015 Jun;74(6):979-84 |
||||
| , Article | ||||
| , Canada, Colombia, France, Germany, Greece, Italy, Mexico, Norway, Portugal, Spain, UK | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431330/ | ||||
| Condition | Year | Language | Analysis type | |
| , Comparative Effectiveness & Health Technology Assessment, Rheumatology | 2015 | English | , Clinical setting: hospital, clinical setting: Secondary care, Prospective study, RWLPR (Real-World Late Phase Research-quintiles | |
| Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting | ||||
| Morais J1, Aguiar C2, McLeod E3, Chatzitheofilou I3, Fonseca Santos I4, Pereira S4 | ||||
| 1 Hospital de Santo André, CHLP, Leiria, Portugal 2 Hospital de Santa Cruz, CHLO, Carnaxide, Portugal 3 IMS Health, London, UK 4 Bayer Portugal, S.A., Carnaxide, Portugal | ||||
| Portuguese Journal of Cardiology, In Press |
||||
| , Article | ||||
| , Portugal | ||||
| Condition | Year | Language | Analysis type | |
| , Cardiovascular disease | 2014 | English | , Cost effectiveness | |
| Health economic evaluation of canagliflozin in the treatment of type 2 diabetes mellitus in Portugal | ||||
| Troelsgaard A1, Knudsen M2, Maia-Lopes S3, Luz M3, Hemels M1 | ||||
| 1Janssen A/S, Birkerød, Denmark, 2IMS Health, Hellerup, Denmark, 3Janssen-Cilag Farmacêutica, Barcarena, Portugal | ||||
| ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
| , Poster | ||||
| , Portugal | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2014 | English | , Economic evaluation | |
| Comparative analysis of Streptococcus pneumoniae transmission in Portuguese and Finnish day-care centres | ||||
| Pessoa D, Hoti F, Syrjänen R, Sá-Leão R, Kaijalainen T, Gabriela M, Gomes M, Auranen K | ||||
| Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), Helsinki, Finland and Department of Vaccination and Immune Protection, National Institute for Health and Welfare (THL), Helsinki, Finland | ||||
| BMC Infect Dis. |
||||
| , Article | ||||
| , Finland, Portugal | ||||
| Abstract: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652738/ | ||||
| Condition | Year | Language | Analysis type | |
| , Infectious disease | 2013 | English | , Longitudinal study | |
| Cost analysis of anemia treatment with erythropoieses-stimulating agents (ESAs) in patients with cancer receiving chemotherapy: a multi-country approach. | ||||
| Duran A1, Spaepen E2, Lamotte M3, Walter E4, Lucioni C5, Pinheiro B6, Brosa M7, Kutikova L8, Pujol B8, Annemans L9 | ||||
| 1 IMS Health, London, United Kingdom 2 SBD Analytics, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Institute for Parmacoeconomic Research, Vienna, Austria 5 Wolters Kluwer Health Italy, Milan, Italy 6 Centre de Investigaçao Sobre Economia Portuguesa, Lisboa, Portugal 7 Oblikue Consulting, Barcelona, Spain 8 Amgen (Europe), Zug, Switzerland 9 I-CHER Interuniversity Centre for Health Economics Research, Gent, Belgium | ||||
| ISPOR 14th Annual European Congress 5-8 November 2011, Madrid, Spain |
||||
| , Poster | ||||
| , Austria, Italy, Portugal, Spain | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2011 | English | , Cost analysis | |
| Modeling cost-effectiveness of drug treatments for severe chronic non-cancer pain in Portugal | ||||
| Obradovic M1, Hertel N2, Ikenberg R3, Gouveia M4, Liedgens H1 | ||||
| 1Grünenthal GmbH, Aachen, Germany, 2IMS Health, London, UK, 3IMS Health GmbH Und Co. Ohg, Nürnberg, Germany, 4Catholic University of Portugal, Lisbon, Portugal | ||||
| ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
| , Poster | ||||
| , Portugal | ||||
| Abstract: http://www.ispor.org/congresses/Spain1111/Posters2.aspx PSY32 | ||||
| Condition | Year | Language | Analysis type | |
| , Neurological disorders | 2011 | English | , Cost effectiveness | |
| Cost-effectiveness of transferring Type-2 Diabetic patients from Neutral Protamine Hagedorn (NPH) To Detemir in Portugal settings | ||||
| Carvalho D1, Lindner L2, Kozarzewski M3 | ||||
| 1São João Hospital, Porto, Porto, Portugal, 2IMS Health, Barcelona, Cataluña, Spain, 3Novo Nordisk Portugal, Lisboa, Lisboa, Portugal | ||||
| ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
| , Poster | ||||
| , Portugal | ||||
| Abstract: http://www.ispor.org/congresses/Spain1111/Posters3.aspx PDB45 | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2011 | English | , Cost effectiveness | |
| Modeling cost-effectiveness of drug treatments for severe chronic non-cancer pain in Portugal | ||||
| Obradovic M.1, Ikenberg R.2, Hertel N.3, Gouveia M.4, Liedgens H.1 | ||||
| 1 Grünenthal GmbH, Aachen, Germany, 2 IMS Consulting Group, Nuremberg, Germany, 3 IMS Consulting Group, London, UK, 4 Católica School of Business and Economics, Lisbon, Portugal | ||||
| ISPOR 14th Annual European Congress, 5th - 8th November, Madrid, Spain |
||||
| , Poster | ||||
| , Portugal | ||||
| Condition | Year | Language | Analysis type | |
| , Pricing and reimbursement | 2011 | English | , Cost effectiveness | |
| Cost-effectiveness of Exenatide Versus Insulin Glargine and Versus Biphasic Insulin Aspart for the Treatment of Type 2 Diabetes in Portugal: A Long-term Health Economic Analysis | ||||
| Palmer JL1, Pinto CG2, Duarte R3, Miguel LS2, Gregor Z4 | ||||
| 1 IMS Health, Basel, Switzerland 2 Centro de Investigação sobre Economia Portuguesa, Lisbon, Portugal 3 Associação Protectora dos Diabéticos, Lisbon, Portugal 4 Eli Lilly and Company, European Health Outcomes Research, Prague, Czech Republic | ||||
| ISPOR 13thAnnual European Congress; Prague, Czech Republic; November 6–9, 2010 |
||||
| , Manuscript in preparation | ||||
| , Portugal | ||||
| Condition | Year | Language | Analysis type | |
| , Diabetes | 2010 | English | , Cost effectiveness | |
| Custo do tratamento do cancro em Portugal. [Cost of cancer care in Portugal]. | ||||
| Araújo A1, Barata F2, Barroso S3, Cortes P4, Damasceno M5, Parreira A6, Espírito Santo J7, Teixeira E8, Pereira R9. | ||||
| 1 Serviço de Oncologia. Instituto Português de Oncologia. Porto 2 Serviço de Pneumologia. Centro Hospitalar de Coimbra. Coimbra 3 Serviço de Oncologia. Hospital do Espírito Santo. Évora 4 Serviço de Oncologia. Hospital de Santa Maria. Lisboa 5 Serviço de Oncologia. Hospital de São João. Porto 6 Departamento de Hematologia. Instituto Português de Oncologia. Lisboa 7 Serviço de Oncologia. Hospital de Nossa Senhora do Rosário. Barreiro 8 Serviço de Pneumologia, Hospital de Santa Maria. Lisboa 9 IMS Health Portugal, HEOR | ||||
| Acta Med Port 2009; 22: 525-536. |
||||
| , Article, Manuscript in preparation | ||||
| , Portugal | ||||
| Condition | Year | Language | Analysis type | |
| , Oncology | 2009 | Spanish | , | |